to nitroolefins which generates products with contiguous
quaternary and tertiary stereocenters.
Scheme 1. Nitrophosphonates in Asymmetric Catalysis
Our initial focus was to identify the best catalyst
and suitable reaction conditions for the aforementioned
Michael reaction. The addition of diethyl(1-nitroethyl)-
phosphonate 1a to ω-nitrostyrene 2a served as the model
reaction toward this effort (Table 1). Rapid evaluation of
the catalyst structure was facilitated by the lack of any
measurable background reaction at room temperature
(entry 1). The catalysts of interest were confined to thiour-
ea-based bifunctional compounds derived from trans-1,2-
diaminocyclohexane or cinchona alkaloids, considering
their well-established mode of substrate activation.11 Not
surprisingly, the reaction was found to be catalyzed by this
type of bifunctional catalysts. In the presence of 10 mol %
of Takemoto catalyst12 I in CH2Cl2, nearly complete
conversion to the desired product 3a (with modest dr)
was observed within 14 h at rt (entry 2). The relative and
absolute stereochemistry of the product was determined by
X-ray analysis (vide infra). Even though 3a was obtained
only with moderate er of 36:64 at rt, lowering the reaction
temperature to 0 °C led to substantial improvement of
enantioselectivity (entry 3). Replacement of an electron-
deficient aryl moiety of the catalyst with cyclohexyl pro-
duced a more active catalyst (II); however the stereoche-
mical integrity of the resulting product was diminished
(entry 4). Catalyst III with bulkier ethyl substituents at the
Brønstedbasictertiaryamine center promoted the reaction
with much poorer enantioselectivity (entry 5). Cinchona
alkaloid-derivedbifunctionalcompoundsIVÀVIIIproved
to be good catalyst candidates (entries 6À10), particularly
the quinine and cinchonine-derived catalysts IV and VII,
respectively.13 The reaction medium was found to have a
dramatic influence on the diastereoselectivity of the reac-
tion (entries 11À16), with trifluorotoluene emerging as the
optimum solvent (entry 16). Reversibility of the reaction at
0 °C turned out to be a barrier toward complete conversion
as slight erosion of both dr and er was observed during the
course of the reaction.14 Further temperature optimization
provided À10 °C as the optimum reaction temperature,
and the product with a consistent dr and er was obtained
over the complete reaction course (entry 18).14
R-Nitrophosphonates can be regarded as immediate
precursors of R-aminophosphonic acids, the straightfor-
ward synthesis of which can be realized via addition to
a potentially wide variety of electrophiles. The use of
parent R-nitrophosphonates is complicated by postreac-
tion epimerization of the R-center, but the corresponding
R-substituted nitrophosphonates are innocuous in this
regard. However the application of substituted R-nitro-
phosphonates as a nucleophile has remained rather
limited. In 2008, Johnston reported a diastereo- and
enantioselective Mannich-type reaction of R-methyl-R-
nitrophosphonates to imines using a chiral Brønsted acid
catalyst (Scheme 1).8 Very recently, during the course of
our investigation, Namboothiri achieved an enantioselec-
tive Michael addition of R-substituted-R-nitrophospho-
nates to vinyl ketones with the help of a bifunctional
catalyst (Scheme 1).9 While the above methods led to the
generation of quaternary R,β-diaminophosphonic acid
and R-aminophosphonic acid precursors, respectively,
there is no report for the enantioselective synthesis of the
precursor of R-substituted R,γ-diaminophosphonic acids.
As part of our research program,10 we became intrigued
by the possibility of accessing such a class of compounds
via an asymmetric CÀC bond formation. It was reasoned
that Michael addition of R-substituted-R-nitrophospho-
nates to nitroolefins would generate such densely functio-
nalized compounds with an additional β-substituent
(Scheme 1). Herein, wereportthefirstcatalytic asymmetric
Michael addition of R-substituted-R-nitrophosphonates
(11) For selected reviews, see: (a) Stegbauer, L.; Sladojevich, F.;
Dixon, D. J. Chem. Sci. 2012, 3, 942–958. (b) Siau, W.-Y.; Wang J.
Catal. Sci. Technol. 2011, 1, 1298–1310. (c) Marcelli, T.; Hiemstra, H.
Synthesis 2010, 1229–1279. (d) Takemoto, Y. Chem. Pharm. Bull. 2010,
58, 593–601. (e) Connon, S. J. Chem. Commun. 2008, 2499–2510. (f)
Doyle, A. G.; Jacobsen, E. N. Chem. Rev. 2007, 107, 5713–5743. (g)
Taylor, M. S.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2006, 45, 1520–
1543. (h) Connon, S. J. Chem.;Eur. J. 2006, 12, 5418–5427. (i)
Takemoto, Y. Org. Biomol. Chem. 2005, 3, 4299–4306.
(12) (a) Sakamoto, S.; Inokuma, T.; Takemoto, Y. Org. Lett. 2011,
13, 6374–6377. (b) Okino, T.; Hoashi, Y.; Takemoto, Y. J. Am. Chem.
Soc. 2003, 125, 12672–12673.
(13) For seminal works on bifunctional cinchona alkaloid-based
thiourea derivatives, see: (a) Bernardi, L.; Fini, F.; Herrera, R. P.;
Ricci, A.; Sgarzani, V. Tetrahedron 2006, 62, 375–380. (b) McCooey,
S. H.; Connon, S. J. Angew. Chem., Int. Ed. 2005, 44, 6367–6370. (c) Ye,
J.; Dixon, D. J.; Hynes, P. S. Chem. Commun. 2005, 4481–4483. (d)
(6) For selected examples, see: (a) Bernardi, L.; Zhuang, W.;
Jørgensen, K. A. J. Am. Chem. Soc. 2005, 127, 5772–5773. (b) Kim,
M. S.; Hye, R. K.; Kim, Y. D. Org. Lett. 2005, 7, 2309–2311.
(7) For reviews, see: (a) Bhaduri, P. S.; Li, H. Synlett 2012, 23, 1108–
1131. (b) Albrecht, Ł.; Albrecht, A.; Krawczyk, H.; Jørgensen, K. A.
Chem.;Eur. J. 2010, 16, 28–48. (c) Bhadury, P. S.; Song, B.-A.; Yang,
S.; Zhang, Y.; Zhang, S. Curr. Org. Synth. 2008, 5, 134–150. (d) Ma,
J.-A. Chem. Soc. Rev. 2006, 35, 630–636.
(8) Wilt, J. C.; Pink, M.; Johnston, J. N. Chem. Commun. 2008, 4177–
4179.
(9) Bera, K.; Namboothiri, I. N. N. Org. Lett. 2012, 14, 980–983.
(10) Manna, M. S.; Kumar, V.; Mukherjee, S. Chem. Commun. 2012,
48, 5193–5195.
ꢀ
ꢀ
Vakulya, B.; Varga, S.; Csampai, A.; Soos, T. Org. Lett. 2005, 7, 1967–
1969. (e) Li, B.-J.; Jiang, L.; Liu, M.; Chen, Y.-C.; Ding, L.-S.; Wu, Y.
Synlett 2005, 603–606.
(14) See Supporting Information for details.
B
Org. Lett., Vol. XX, No. XX, XXXX